biostudies-literatureMorales-Marroquin ENIMHD NIH HHS1539-1545https://www.ebi.ac.uk/biostudies/studies/S-EPMC12292007biostudies-literatureUnknown32(5)<h4>Purpose</h4>Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.<h4>Methods</h4>Retrospective analysis of 2015-2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher's exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.<h4>Results</h4>The use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26-38 min).<h4>Conclusion</h4>Robotic MBS shows higher intervention and readmission even after controlling for cofounding variables.Obesity surgeryFive Year Trends in the Utilization of Robotic Bariatric Surgery Procedures, United States 2015-2019.PMC12292007R01 MD011686Qureshi FGKhatiwada SKukreja SMessiah SESchneider BXie Lde la Cruz-Munoz NMorales-Marroquin EfalseFive Year Trends in the Utilization of Robotic Bariatric Surgery Procedures, United States 2015-2019.<h4>Purpose</h4>Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.<h4>Methods</h4>Retrospective analysis of 2015-2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher's exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.<h4>Results</h4>The use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26-38 min).<h4>Conclusion</h4>Robotic MBS shows higher intervention and readmission even after controlling for cofounding variables.2022-01-01T00:00:00Z2022 May2026-03-15T17:00:13.109Z2025-08-13T03:04:15.714ZS-EPMC122920073516995310.1007/s11695-022-05964-7